Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

175.63
BATS BZX Real-Time Price
As of 12:54pm ET
 +0.82 / +0.47%
Today’s Change
169.61
Today|||52-Week Range
256.80
-16.37%
Year-to-Date
AGN Regular Dividend: AGN began trading ex-dividend on 11/16/17. A $0.70 dividend will be paid to shareholders of record as of 11/17/17.

Today’s Trading

Previous close174.81
Today’s open174.00
Day’s range172.92 - 176.21
Volume85,182
Average volume (3 months)3,073,430
Market cap$58.1B
Dividend yield1.59%
Data as of 12:54pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.26%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.82

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.09-0.27%
ABTAbbott Laboratories-0.02-0.04%
LLYEli Lilly and Co-0.51-0.61%
NVONovo Nordisk+0.39+0.77%
Data as of 12:55pm ET, 11/17/2017

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$4.74
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts